مباشر

Endpoints NewsActing FDA commissioner pledges to prevent political interference in rare disease meeting Endpoints NewsDimension seeks up to $750M for third life sciences fund after string of success Endpoints NewsElevance talks 'practical' AI Endpoints NewsMammalian hair, roof leaks: Novo's Catalent site in Indiana under FDA scrutiny once again FierceBiotechAutobahn races toward pivotal trial after thyroid hormone mimic eases bipolar depression in ph. 2 Lonza NewsLonza, Stipple Bio Sign ADC Licensing Deal - Contract Pharma Endpoints NewsHikma to funnel $267M to Ohio; Cingulate gets CRL for ADHD drug CellPaleogenomes reveal the evolutionary relationship between modern and cave lions Endpoints NewsLilly, Boehringer retrench in Germany on proposed health spending cuts Endpoints NewsSupreme Court sides with Hikma in 'skinny label' case FierceBiotechAs China biotech crackdown calls reverberate in Washington, the pushback gets louder, too BioWorldDeaths mar ADC’s confirmatory trial with Zynlonta in DLBCL

Endpoints News ٤ يونيو ٢٠٢٦

Mammalian hair, roof leaks: Novo's Catalent site in Indiana under FDA scrutiny once again

Novo Nordisk’s troubled factory in Indiana that it got from Catalent continues to face contamination issues, with a re-inspection in April finding mammalian hai...

Novo Nordisk’s troubled factory in Indiana that it got from Catalent continues to face contamination issues, with a re-inspection in April finding mammalian hair in finished drugs and water leaks that compromise product sterility. The ...